Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)

被引:33
|
作者
Fortunati, N
Fissore, F
Fazzari, A
Piovano, F
Catalano, MG
Becchis, M
Berta, L
Frairia, R
机构
[1] Univ Turin, Lab Endocrinol, UOADU Med Gen 2, Azienda Osped S Giovanii Bta, I-10126 Turin, Italy
[2] Univ Turin, Dipartimento Fisiopatol Clin, I-10126 Turin, Italy
关键词
D O I
10.1016/S0960-0760(99)00092-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma sex hormone-binding globulin (SHBG or SEP), the specific carrier for estradiol and androgens, after binding to its membrane receptor (SHBG-R), causes a significant increase of cAMP in the presence of estradiol, in both breast (MCF-7) and prostate (LNCaP) cancer cells maintained in serum-free medium. On the other hand, it has been proposed that estrogens, in addition to the well-known nuclear receptor pathway, exert their biological effect inducing cAMP, as a consequence of a direct membrane action, in breast cancer and uterine cells. The aim of the present study was to clarify this controversial issue by verifying if the cAMP increase in MCF-7 cells was a direct effect of estradiol, or if it was mediated by FCS proteins, such as bovine sex hormone-binding globulin; and to reevaluate the effect of human SHBG on cAMP induction in the presence of FCS. MCF-7 cells were maintained in DCC-FCS (treated with DCC to remove steroids), in SHBG-FREE/DCC-FCS (treated with DCC and with a specific affinity chromatography to remove bovine sex hormone-binding globulin), or in serum-free medium (SFM). It was observed that estradiol determined a significant time-dependent increase of cAMP only in MCF-7 cells maintained in 10% DCC-FCS. When cells were maintained in 10% SHBG-FREE/DCC-FCS, estradiol had no detectable effect. However, its ability to increase cAMP was observed again after the addition of human SHBG, in doses ranging from 5 to 50 nM. Moreover, in the presence of 10% SHBG-FREE/DCC-FCS, SHBG, even in the absence of estradiol, caused a significant increase of cAMP. In conclusion, the data reported in the present study suggest that the ability of estradiol to induce cAMP in MCF-7 cells is not due to a direct membrane effect of the hormone, but rather it is mediated by FCS. SHBG is one of the serum factors mediating estradiol action. Lastly, it was proven that SHBG triggers the cAMP pathway in MCF-7 cells in a physiologic culture condition and at physiologic concentrations. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [41] Steroid-binding characteristics of sex hormone-binding globulin (SHBG) in carp, Cyprinus carpio
    M. Okunaga
    T. Matsubara
    N. Ohkubo
    M. Nagae
    Fish Physiology and Biochemistry, 2003, 28 : 219 - 220
  • [42] SERUM SEX HORMONE-BINDING GLOBULIN (SHBG) AND NON-SHBG-BOUND TESTOSTERONE IN PREPUBERTAL BOYS WITH CHRONIC RENAL-INSUFFICIENCY
    BELGOROSKY, A
    FERRARIS, JR
    RAMIREZ, JA
    RIVAROLA, MA
    PEDIATRIC RESEARCH, 1990, 28 (04) : 423 - 423
  • [43] Regulation of serum sex hormone-binding globulin (SHBG) levels by plasma insulin in male NIDDM patients.
    Katsuki, A
    Sumida, Y
    Fujii, M
    Ito, K
    Tsuchihashi, K
    Murata, K
    Goto, H
    Makatani, K
    Yano, Y
    Shima, T
    DIABETES, 1996, 45 : 1219 - 1219
  • [44] Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women
    Adly, Laila
    Hill, Deirdre
    Sherman, Mark E.
    Sturgeon, Susan R.
    Fears, Thomas
    Mies, Carolyn
    Ziegler, Regina G.
    Hoover, Robert N.
    Schairer, Catherine
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) : 2402 - 2407
  • [45] CHANGES IN SERUM SEX HORMONE-BINDING GLOBULIN AND IN SERUM NON-SEX HORMONE-BINDING GLOBULIN-BOUND TESTOSTERONE DURING PREPUBERTY IN BOYS
    BELGOROSKY, A
    RIVAROLA, MA
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 27 (1-3): : 291 - 295
  • [46] SEX HORMONE-BINDING GLOBULIN (SHBG) IS NOT A RELIABLE INDICATOR OF ANDROGENICITY IN DANAZOL TREATED PATIENTS
    GERSHAGEN, S
    RANNEVIK, G
    ACTA ENDOCRINOLOGICA, 1981, 97 : 214 - 214
  • [47] Immunolocalization of sex hormone-binding globulin (SHBG) in human ovarian follicles and corpus luteum
    Forges, T
    Gérard, A
    Monnier-Barbarino, P
    Gérard, H
    HISTOCHEMISTRY AND CELL BIOLOGY, 2005, 124 (3-4) : 285 - 290
  • [48] SEX HORMONE-BINDING GLOBULIN AND THE NATURAL-HISTORY OF BREAST-CANCER
    BULBROOK, RD
    MOORE, JW
    ALLEN, D
    THOMAS, BS
    GRAVELLE, IH
    HAYWARD, JL
    WANG, DY
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 538 : 248 - 256
  • [49] Association between sex hormone-binding globulin (SHBG) and metabolic syndrome among men
    Callou de Sa, Emmanuela Quental
    Feijo de Sa, Francisco Carleial
    Oliveira, Kelly Cristina
    Feres, Fausto
    Nascimento Verreschi, Ieda Therezinha
    SAO PAULO MEDICAL JOURNAL, 2014, 132 (02): : 111 - 115
  • [50] Interactions of sex hormone-binding globulin with target cells
    Rosner, William
    Hryb, Daniel J.
    Kahn, Scott M.
    Nakhla, Atif M.
    Romas, Nicholas A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 316 (01) : 79 - 85